Shao Kang Wang
Vorstandsvorsitzender bei Infervision Medical Technology Co., Ltd.
Profil
Shao Kang Wang is currently the Executive Director & General Manager at Infervision Medical Technology Co., Ltd.
and a Member-Supervisory Board at Shanghai Infervision Biotechnology Co. Ltd.
He graduated from The University of Chicago in 2012 with a graduate degree and from Beijing Institute of Technology in 2010 with an undergraduate degree.
Aktive Positionen von Shao Kang Wang
Unternehmen | Position | Beginn |
---|---|---|
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Vorstandsvorsitzender | 05.01.2016 |
Shanghai Infervision Biotechnology Co. Ltd. | Direktor/Vorstandsmitglied | 01.01.2020 |
Ausbildung von Shao Kang Wang
Beijing Institute of Technology | Undergraduate Degree |
The University of Chicago | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Technology Services |
Shanghai Infervision Biotechnology Co. Ltd. |